Verly IRN - Search Results

1

Hypermethylated RASSF1A as Circulating Tumor DNA Marker for Disease Monitoring in Neuroblastoma.

van Zogchel LMJ, van Wezel EM, van Wijk J, Stutterheim J, Bruins WSC, Zappeij-Kannegieter L, Slager TJE, Schumacher-Kuckelkorn R, Verly IRN, van der Schoot CE, Tytgat GAM. van Zogchel LMJ, et al. Among authors: verly irn. JCO Precis Oncol. 2020 Apr 14;4:PO.19.00261. doi: 10.1200/PO.19.00261. eCollection 2020. JCO Precis Oncol. 2020. PMID: 32923888 Free PMC article.

2

Catecholamines profiles at diagnosis: Increased diagnostic sensitivity and correlation with biological and clinical features in neuroblastoma patients.

Verly IR, van Kuilenburg AB, Abeling NG, Goorden SM, Fiocco M, Vaz FM, van Noesel MM, Zwaan CM, Kaspers GL, Merks JH, Caron HN, Tytgat GA. Verly IR, et al. Eur J Cancer. 2017 Feb;72:235-243. doi: 10.1016/j.ejca.2016.12.002. Epub 2017 Jan 4. Eur J Cancer. 2017. PMID: 28061374

3

3-Methoxytyramine: An independent prognostic biomarker that associates with high-risk disease and poor clinical outcome in neuroblastoma patients.

Verly IRN, van Kuilenburg ABP, Abeling NGGM, Goorden SMI, Fiocco M, Vaz FM, van Noesel MM, Zwaan CM, Kaspers GJL, Merks JHM, Caron HN, Tytgat GAM. Verly IRN, et al. Eur J Cancer. 2018 Feb;90:102-110. doi: 10.1016/j.ejca.2017.11.025. Epub 2017 Dec 21. Eur J Cancer. 2018. PMID: 29274926

4

Catecholamine excretion profiles identify clinical subgroups of neuroblastoma patients.

Verly IRN, Leen R, Meinsma JR, Hooijer GKJ, Savci-Heijink CD, van Nes J, Broekmans M, Wanders RJA, van Kuilenburg ABP, Tytgat GAM. Verly IRN, et al. Eur J Cancer. 2019 Apr;111:21-29. doi: 10.1016/j.ejca.2019.01.014. Epub 2019 Feb 22. Eur J Cancer. 2019. PMID: 30798085

5

Plasma free metanephrines for diagnosis of neuroblastoma patients.

Barco S, Verly I, Corrias MV, Sorrentino S, Conte M, Tripodi G, Tytgat G, van Kuilenburg A, van der Ham M, de Sain-van der Velden M, Garaventa A, Cangemi G. Barco S, et al. Clin Biochem. 2019 Apr;66:57-62. doi: 10.1016/j.clinbiochem.2019.02.012. Epub 2019 Feb 26. Clin Biochem. 2019. PMID: 30822416

6

Urinary 3-Methoxytyramine Is a Biomarker for MYC Activity in Patients With Neuroblastoma.

Verly IRN, Matser YAH, Leen R, Meinsma R, Fiocco M, Koster J, Volckmann R, Savci-Heijink D, Cangemi G, Barco S, Valentijn LJ, Tytgat GAM, van Kuilenburg ABP. Verly IRN, et al. JCO Precis Oncol. 2022 Jan;6:e2000447. doi: 10.1200/PO.20.00447. JCO Precis Oncol. 2022. PMID: 35085004 Free PMC article.

7

Optimising urinary catecholamine metabolite diagnostics for neuroblastoma.

Matser YAH, Verly IRN, van der Ham M, de Sain-van der Velden MGM, Verhoeven-Duif NM, Ash S, Cangemi G, Barco S, Popovic MB, van Kuilenburg ABP, Tytgat GAM; SIOPEN Catecholamine Working Group. Matser YAH, et al. Among authors: verly irn. Pediatr Blood Cancer. 2023 Jun;70(6):e30289. doi: 10.1002/pbc.30289. Epub 2023 Apr 3. Pediatr Blood Cancer. 2023. PMID: 37010353

8

miR expression profiling at diagnosis predicts relapse in pediatric precursor B-cell acute lymphoblastic leukemia.

Avigad S, Verly IR, Lebel A, Kordi O, Shichrur K, Ohali A, Hameiri-Grossman M, Kaspers GJ, Cloos J, Fronkova E, Trka J, Luria D, Kodman Y, Mirsky H, Gaash D, Jeison M, Avrahami G, Elitzur S, Gilad G, Stark B, Yaniv I. Avigad S, et al. Genes Chromosomes Cancer. 2016 Apr;55(4):328-39. doi: 10.1002/gcc.22334. Epub 2015 Dec 19. Genes Chromosomes Cancer. 2016. PMID: 26684414

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8 results

Search Page